Tag: licensing
-
Celgene, MorphoSys Partner on Multiple Myeloma Antibody
Celgene Corporation, a biopharmaceutical company in Summit, New Jersey, agreed to license technology and invest in the biotechnology company MorphoSys AG in Munich, Germany for commercializing a monoclonal antibody developed by MorphoSys to treat multiple myeloma and some forms of leukemia. The total potential value of the deal, if all contingencies are met, is €628…
-
VC Fund Gains $100M for University, Defense Lab Spinoffs
Allied Minds, a venture capital (VC) company in Boston starting companies that commercialize research from university and U.S. federal labs, raised $100 million for its next series of investments. The company says closing this funding round brings its total assets to about $500 million. Allied Minds makes early-stage investments, sometimes soon after the point of…
-
Biotech Developing Genetics Therapies Gains $101M in IPO
The biotechnology company bluebird bio in Cambridge, Massachusetts developing therapies for genetic disorders raised $101 million through its initial public offering (IPO) of 5.9 million shares priced at $17.00 a share. The company’s stock, trading on the NASDAQ under the code BLUE was priced at $26.00 a share at 11:00 am ET today. bluebird bio…
-
Stem Cells Generate High-Quality Liver Cells for Drug Tests
Medical researchers at University of Edinburgh in Scotland created a process for inducing pluripotent stem cells to transform into liver cells with the same consistency and quality needed to test drugs for toxicity. A spin-off company from the university has also formed to take the research to market. The team led by Edinburgh’s David Hay…
-
University Patents, Licenses Cattle Feed Supplement
Kansas State University in Manhattan received a patent and licensed a nutritional supplement for cattle feed developed by one of its faculty members. Research by animal sciences professor Jim Drouillard led to development of a supplement that improves absorption of omega-3 fatty acids beneficial to livestock, which Kansas State patented earlier this year and licensed…
-
GSK Licenses Biotech Antibody for Arthritis, MS Drugs
The biotechology company MorphoSys AG in Germany says the pharmaceutical company GlaxoSmithKline is licensing its targeted human antibody drug candidate MOR103 to treat rheumatoid arthritis. The deal has a potential value to MorphoSys of €445.5 million ($US 579 million), not counting future sales royalties. MorphoSys develops engineered antibodies for therapies and diagnostics. One of its…
-
FuturaGene, Danforth Center Partner on Crop Yield Technology
FuturaGene, a Sao Paulo, Brazil biotechnology company in the forestry industry will collaborate with Donald Danforth Plant Science Center in St. Louis to apply FuturaGen’s yield enhancement discoveries to food crops in developing countries. Financial and intellectual property aspects of the deal were not disclosed. FuturaGene, a subsidiary of the Brazilian forestry products company Suzano…
-
Purdue Licenses Reagent for Safer Fluorine Compounds
Purdue University in Indiana licensed a reagent developed and patented by one of its organic chemists that makes it safer and more environmentally friendly to add fluorine to organic compounds. The university licensed the reagent, developed in Purdue’s chemistry and pharmacology labs under the direction of professor David Colby, to Aldrich Chemical Co., a subsidiary of…
-
Faster Process Developed to Find Therapeutic Antibodies
Researchers at Scripps Research Institute in La Jolla, California and Scripps Korea Antibody Institute developed a new process to more rapidly identify antibodies that target specific disease molecules. The team from the lab of Richard Lerner, an immunochemistry professor at and former director of Scripps, published its findings yesterday in the journal Chemistry & Biology…
-
Start-Up Creating Audio Technology from UC Davis Research
A two year-old company spun-off from University California in Davis is designing a new type of audio experience based on research in the school’s engineering department. Dysonics Inc., located in San Francisco, was founded by three Davis engineering faculty members, bringing to market more than a decade of research on multi-dimensional audio from the university’s…